Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Asıl Yazarlar: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Oxford University Press
2018
|
Benzer Materyaller
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
Yazar:: Wattanakul, T, ve diğerleri
Baskı/Yayın Bilgisi: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
Yazar:: Thanaporn Wattanakul, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
Yazar:: Chotsiri, P, ve diğerleri
Baskı/Yayın Bilgisi: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
Yazar:: Pukrittayakamee, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
Yazar:: Saito, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)